Molecular Formula | C9H5NO2 |
Molar Mass | 159.14 |
Density | 1.36±0.1 g/cm3(Predicted) |
Melting Point | 201-205°C(lit.) |
Boling Point | 407.5±45.0 °C(Predicted) |
Flash Point | 199.3°C |
Solubility | Acetone (Slightly), Chloroform (Slightly), Methanol (Slightly) |
Vapor Presure | 0.012Pa at 25℃ |
Appearance | Yellow crystal |
Color | White to light yellow |
Storage Condition | Sealed in dry,Room Temperature |
Refractive Index | 1.606 |
MDL | MFCD01072882 |
Physical and Chemical Properties | Melting Point 202-204°C |
Use | Pharmaceutical intermediates. An important intermediate for the preparation of citalopram, a therapeutic agent for metastatic breast cancer. |
Risk Codes | R20/21/22 - Harmful by inhalation, in contact with skin and if swallowed. R36/37/38 - Irritating to eyes, respiratory system and skin. |
Safety Description | S36/37 - Wear suitable protective clothing and gloves. S36 - Wear suitable protective clothing. S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. |
UN IDs | 3439 |
WGK Germany | 3 |
HS Code | 29322090 |
LogP | 0.136 at 30℃ and pH5.03 |
dissociation constant | 0-0at 30 ℃ |
Use | pharmaceutical intermediates. An important intermediate for the preparation of citalopram, a therapeutic agent for metastatic breast cancer. pharmaceutical intermediates. An important intermediate for the preparation of citalopram, a therapeutic agent for metastatic breast cancer. Used as pharmaceutical intermediates for the preparation of metastatic breast cancer treatment drugs citalopram, etc. for the preparation of metastatic breast cancer treatment drugs citalopram, etc. |